These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Volm M; Hahn EW; Mattern J; Müller T; Vogt-Moykopf I; Weber E Cancer Res; 1988 May; 48(10):2923-8. PubMed ID: 2834052 [TBL] [Abstract][Full Text] [Related]
47. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up]. Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555 [TBL] [Abstract][Full Text] [Related]
48. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Herbst RS; Yano S; Kuniyasu H; Khuri FR; Bucana CD; Guo F; Liu D; Kemp B; Lee JJ; Hong WK; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):790-7. PubMed ID: 10741698 [TBL] [Abstract][Full Text] [Related]
49. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer]. Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K Pneumologie; 2000 Aug; 54(8):355-60. PubMed ID: 11008478 [TBL] [Abstract][Full Text] [Related]
50. The present status of surgery for lung cancer. Lacquet LK Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764 [TBL] [Abstract][Full Text] [Related]
51. Prognostic value of angiogenesis in operable non-small cell lung cancer. Giatromanolaki A; Koukourakis M; O'Byrne K; Fox S; Whitehouse R; Talbot DC; Harris AL; Gatter KC J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350 [TBL] [Abstract][Full Text] [Related]
52. Subcategorization of resectable non-small cell lung cancer involving neighboring structures. Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135 [TBL] [Abstract][Full Text] [Related]
53. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature]. Jeanfaivre T; Chassevent A; Larra F; Tuchais E Bull Cancer; 1994 Jul; 81(7):605-9. PubMed ID: 7742603 [TBL] [Abstract][Full Text] [Related]
54. Postoperative T1 N0 non-small cell lung cancer. Squamous versus nonsquamous recurrences. The Lung Cancer Study Group. J Thorac Cardiovasc Surg; 1987 Sep; 94(3):349-54. PubMed ID: 3041124 [TBL] [Abstract][Full Text] [Related]
55. Results of long-term follow-up of patients with completely resected non-small cell lung cancer. Endo C; Sakurada A; Notsuda H; Noda M; Hoshikawa Y; Okada Y; Kondo T Ann Thorac Surg; 2012 Apr; 93(4):1061-8. PubMed ID: 22386090 [TBL] [Abstract][Full Text] [Related]
56. [Studies on flow cytometric analysis of nuclear DNA content in non-small cell lung cancer]. Isobe H Hokkaido Igaku Zasshi; 1991 Jan; 66(1):49-58. PubMed ID: 1848524 [TBL] [Abstract][Full Text] [Related]
57. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer]. Morita K; Hayashi Y; Nagao S; Watanabe Y Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782 [TBL] [Abstract][Full Text] [Related]
58. Refractory remodeling of the microenvironment by abnormal type V collagen, apoptosis, and immune response in non-small cell lung cancer. Souza P; Rizzardi F; Noleto G; Atanazio M; Bianchi O; Parra ER; Teodoro WR; Carrasco S; Velosa AP; Fernezlian S; Ab'saber AM; Antonângelo L; Takagaki T; Schainberg CG; Yoshinari NH; Capelozzi VL Hum Pathol; 2010 Feb; 41(2):239-48. PubMed ID: 19828174 [TBL] [Abstract][Full Text] [Related]
59. Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival. Trost Z; Sok M; Marc J; Cerne D Arch Med Res; 2009 Jul; 40(5):364-8. PubMed ID: 19766899 [TBL] [Abstract][Full Text] [Related]
60. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer. The Lung Cancer Study Group. Thomas PA; Rubinstein L J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1053-8. PubMed ID: 8246538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]